Purchase Order HHSN269201700588P
Award Date 8/4/17
Potential Completion Date 8/10/17
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $15,090 on July 28, 2017, with ultimate completion by August 27, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The purchase covers molecular diagnostics products and consumables, consistent with Qiagen's core offerings in DNA/RNA extraction kits, reagents, and related laboratory supplies supporting the Clinical Center's biomedical research and diagnostic...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,064 purchase order to Qiagen, LLC. Under this firm fixed price contract, Qiagen will provide products or services to the NIH Clinical Center in Germantown, Maryland between September 2023 and September 2024. As a division of Qiagen N.V., Qiagen, LLC will leverage its parent company's expertise in sample and assay technologies to support the NIH Clinical Center's biomedical research and...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC valued at $17,029.90 on August 24, 2018, with ultimate completion on August 24, 2019. The order is a firm fixed-price acquisition with no set-aside designation. Performance occurs in Valencia, California. The source does not specify the products or services procured under this order.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $80,260 on March 28, 2019, with ultimate completion on April 14, 2021. No set-aside was used. The order covers molecular diagnostics products and related supplies, with firm fixed-price pricing. Performance occurs at Bethesda, Maryland.</p>
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $15,500.00 with an award date of March 13, 2020 and ultimate completion date of March 12, 2021. Performance occurs in Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. The specific commodities or services procured are not detailed in the source.</p>
- The National Institutes of Health Clinical Center awarded a $66,070 firm fixed-price purchase order to Qiagen, LLC on April 15, 2026, with an ultimate completion date of April 14, 2027. This contract represents a child award issued under a larger indefinite delivery vehicle and carries no small business set-aside designation. Qiagen, headquartered in Germantown, Maryland, is a specialized supplier of molecular diagnostics products, scientific equipment, and bioinformatics solutions. The...
- Qiagen, LLC received a $29,166.25 firm fixed-price purchase order from the NIH Clinical Center, awarded on January 1, 2026, with a completion date of December 31, 2026. This contract carries no set-aside designation, allowing Qiagen to compete in the open federal marketplace. The award is for delivery to Germantown, Maryland, where Qiagen maintains its headquarters operations. As a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $11,449.80 firm fixed price purchase order to Qiagen, LLC for the performance of clinical testing in the molecular diagnostics laboratory of the microbiology service. Qiagen will provide products and services to support the required testing through March 2024. No set-aside designation was applied to this award. Qiagen is an international provider of sample and assay technologies for molecular...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,433 firm fixed price purchase order to Qiagen, LLC for unspecified products or services. Qiagen, a subsidiary of Qiagen N.V., will perform the contract from its location in Bethesda, Maryland over a one year period ending August 2024. No additional details were provided regarding the original solicitation or scope of work. However, based on the funding agency, the products or services are...
- <p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $33,152.18 on May 16, 2019, with firm fixed pricing and a ceiling value of $33,152.18. Performance is located in Germantown, Maryland, with ultimate completion by May 31, 2020. The order was issued without a small business set-aside. No solicitation details regarding the specific items or services procured are provided in the source.</p>
The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.
Generated 6/4/26, 11:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($15) | 8/4/17 | |
| Not listed | Not listed | $12.8k | 8/3/17 |